Two popular high-yield stocks flashing major warning signs for income investors. Chasing sky-high dividends could be setting you up for a painful payout cut. Hidden risks are lurking behind two of today's most tempting high-yield opportunities.
A rise in NII, along with higher loan and deposit balances, aids BPOP's Q1 earnings. Yet, a fall in fee income is a headwind.
Popular, Inc. (NASDAQ:BPOP ) Q1 2025 Earnings Conference Call April 23, 2025 11:00 AM ET Company Participants Paul Cardillo - Senior Vice President and Investor Relations Officer Ignacio Alvarez - Chief Executive Officer Javier Ferrer - President and Chief Operating Officer Jorge Garcia - Executive Vice President and Chief Financial Officer Lidio Soriano - Executive Vice President and Chief Risk Officer Conference Call Participants Frank Schiraldi - Piper Sandler Gerard Cassidy - RBC Capital Markets Timur Braziler - Wells Fargo Jared Shaw - Barclays Benjamin Gerlinger - Citi Kelly Motta - KBW Ynyra Bohan - Hovde Group Operator Hello and welcome to the Popular Incorporated First Quarter 2025 Earnings Call. My name is Elliot.
Popular (BPOP) came out with quarterly earnings of $2.56 per share, beating the Zacks Consensus Estimate of $2.26 per share. This compares to earnings of $1.87 per share a year ago.
Popular (BPOP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Popular (BPOP) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
These three investor favorites are quietly flashing red warning signals. Find out which popular income plays could be primed for painful pullbacks. We also discuss better alternatives for each one.
Palantir Technologies (PLTR -4.71%) and Tesla (TSLA -3.42%) are two of the most popular stocks among individual investors, but some Wall Street analysts think shareholders will see potentially catastrophic losses in the next year:
Various ETFs have experienced an uptick in ETF outflows since the year began. Undoubtedly, the recent March correction driven by mounting tariff fears has pushed investors to take profits and rotate towards more defensive names.
The company, which went public in 2021, has never turned a profit. Transcript: Loren Torres: 23andMe, which gave customers “personalized genetic insights” through its at-home DNA testing kits, has filed for bankruptcy.
Several stocks have been gaining big attention as of late, a list that includes Alibaba BABA, Palantir PLTR, and Vertiv VRT. Let's take a closer look at each to see how they presently stack up.
Uncertainty is the market's current buzz word. Concerns about policy, recession risk, inflation, consumer confidence, economic growth, and geopolitics have stock prices on a rollercoaster ride this year.